Engineering Precision In Genetic Medicines: Inside ElevateBio's Genomic Medicine Toolbox

Permanent DNA edits leave little room for compromise. Therapeutic gene editing requires technologies that can reach clinically relevant targets, deliver potent activity, and minimize unintended edits. ElevateBio combines a curated catalog of more than 10 billion protein sequences with novel enzyme discovery and AI-driven optimization to engineer editors around these three essential criteria. Examples include PAM engineering that expands access to more than 90% of ClinVar pathogenic variants, allele-selective editing for Huntington’s disease, and adenine base editors designed for clinical-grade specificity. The platform also supports targeted gene insertion, RT editing, and epigenetic editing, creating multiple paths for addressing complex therapeutic targets.

Learn how systematic enzyme engineering can overcome the limitations of early-generation editors.